Publication | Closed Access
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
150
Citations
44
References
2010
Year
Hematological MalignancyCell SignalingReceptor Tyrosine KinaseImmunologyFgfr3 SignalingCell BiologyMedicineRadiation OncologyCancer ResearchTumor BiologyJak-stat Signaling Pathway
| Year | Citations | |
|---|---|---|
Page 1
Page 1